31 completed, 12 unknown, 7 recruiting, 6 active not recruiting. 64 Phase 2, 3 Phase 1, 1 Phase 3.
Follow Bleomycin: new trials by email Literature Review of Bleomycin trials Research Report on Bleomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST) Bleomycin Sulfate - Vascular Malformations | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 140 | 2026-09-10 | 2026-10-09 |
| Injection Sclerotherapy With Bleomycin VS Doxycycline in Patients With Lymphatic Malformations Bleomycin, doxycycline (tetracycline) - Lymphatic Abnormality | Phase 2 | Not yet recruiting | Basharat Hussain | 92 | 2026-01-26 | 2026-01-06 |
| A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. Bleomycin injection, Cryotherapy - Verruca Plantaris | Phase 1 / Phase 2 | Recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 70 | 2024-12-25 | 2025-03-24 |
| Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline Paclitaxel, Bleomycin, Etoposide - Germ Cell Cancer Metastatic | Phase 2 | Recruiting | Blokhin's Russian Cancer Research Center | 60 | 2024-10-01 | 2026-10-26 |
| PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin - Seminoma | Phase 2 | Recruiting | Heinrich-Heine University, Duesseldorf | 60 | 2023-08-28 | 2025-09-15 |
| ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study Bleomicina - Paget Disease of the Vulva, Vulva Cancer | Phase 2 | Active not recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 18 | 2023-05-23 | 2025-08-08 |
| Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients Bleomycin - Lymphatic Malformation | Phase 2 | Recruiting | West China Hospital | 200 | 2023-03-08 | 2024-06-03 |
| Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer Carboplatin, Bleomycin - Vulvar Cancer | Phase 2 | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 92 | 2022-04-08 | 2022-05-27 |
| Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) Pembrolizumab, Doxorubicin, Vinblastine - Classical Hodgkin Lymphoma | Phase 2 | Completed | Merck Sharp & Dohme LLC | 146 | 2021-10-07 | 2025-06-06 |
| Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts Bleomycin Injection, Cryotherapy - Cutaneous Warts | Phase 2 | Completed | Jinnah Postgraduate Medical Centre | 154 | 2021-01-01 | 2021-08-26 |
| Electrochemotherapy of Gynecological Cancers Electrochemotherapy with bleomycin or cisplatin - Gynecological Cancers | Phase 2 | Recruiting | Institute of Oncology Ljubljana | 30 | 2020-07-01 | 2024-10-17 |
| Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 bendamustine, Etoposide, Doxorubicin - Hodgkin Lymphoma | Phase 2 | Active not recruiting | St. Jude Children's Research Hospital | 232 | 2018-12-12 | 2026-06-17 |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma Bleomycin, Brentuximab Vedotin, Dacarbazine - Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 159 | 2018-11-28 | 2026-10-29 |
| Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) pembrolizumab, doxorubicin, vinblastine - Hodgkin Lymphoma | Phase 2 | Active not recruiting | Merck Sharp & Dohme LLC | 340 | 2018-04-09 | 2026-11-04 |
| OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy Adriamycin, Cyclophosphamide, Vinblastine - Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category) | Phase 2 | Unknown | King Abdullah International Medical Research Center | 220 | 2018-01-01 | 2019-11-18 |
| A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) doxorubicin, Bleomycin, vinblastine - Hodgkin Lymphoma | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 82 | 2017-01-25 | 2026-02-17 |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer Electrochemotherapy with bleomycin, EndoVE - Locally Advanced Rectal Cancer, Electrochemotherapy | Phase 2 | Unknown | Zealand University Hospital | 40 | 2017-01-01 | 2019-01-25 |
| Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD brentuximab vedotin, Cyclophosphamide, Adriamycin - Hodgkin Lymphoma | Phase 2 | Completed | The Lymphoma Academic Research Organisation | 40 | 2015-04-01 | 2021-07-26 |
| Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. Doxorubicin, Bleomycin, Vinblastine - Hodgkin Lymphoma | Phase 2 | Completed | The Lymphoma Academic Research Organisation | 170 | 2015-03-01 | 2022-08-19 |
| Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor Carboplatin, Etoposide, Cyclophosphamide - Intracranial Non-germinomatous Germ Cell Tumor | Phase 2 | Unknown | Samsung Medical Center | 25 | 2014-04-01 | 2020-03-19 |
Showing 20 of 64. Sign in to see all of them.
Hodgkin Disease (25) · Lymphoma (19) · Testicular Neoplasms (6) · Teratoma (4) · Carcinoma, Embryonal (3) · Endodermal Sinus Tumor (3) · HIV Infections (3) · Lymphoma, Large B-Cell, Diffuse (3) · Neoplasms (3) · Neoplasms, Germ Cell and Embryonal (3) · Recurrence (3) · Seminoma (3) · Testicular Germ Cell Tumor (3) · Acquired Immunodeficiency Syndrome (2) · Burkitt Lymphoma (2)
M.D. Anderson Cancer Center (4) · Stanford University (4) · Memorial Sloan Kettering Cancer Center (3) · SWOG Cancer Research Network (3) · Children's Oncology Group (2) · Copenhagen University Hospital at Herlev (2) · Institute of Oncology Ljubljana (2) · Merck Sharp & Dohme LLC (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Samsung Medical Center (2) · St. Jude Children's Research Hospital (2) · The Lymphoma Academic Research Organisation (2) · Alliance for Clinical Trials in Oncology (1) · American Scitech International (1) · Basharat Hussain (1)
United States (31) · United Kingdom (8) · Denmark (7) · France (7) · Germany (7) · Italy (7) · Netherlands (5) · Canada (4) · Australia (3) · Belgium (3) · Poland (3) · South Korea (3) · Spain (3) · China (2) · Israel (2)
Sandra J. Horning, MD (3) · Anas Younes, MD (2) · Lode J. Swinnen, MD (2) · Alain Delmer, MD (1) · Alex F Herrera (1) · Alison Moskowitz, MD (1) · Andrea Necchi, MD (1) · Andreas Josting, Dr. (1) · Ayman Hejazi, MD (1) · Baris Karakullukcu, MD (1) · Bertrand Coiffier, MD (1) · Carl E. Allen, MD, PhD (1) · Darren Feldman, MD (1) · David J. Straus, MD (1)
PMID 40135712, PMID 14508361, PMID 15999362, PMID 18645482, PMID 20551376, PMID 21079154, PMID 22371887, PMID 22731832, PMID 25001888, PMID 25344361, PMID 28816072, PMID 30049811, PMID 30723079, PMID 31331918, PMID 31734224, PMID 32502506, PMID 35867960, PMID 36271467, PMID 37423005, PMID 37505794, PMID 39265466, PMID 39620432, PMID 39661923, PMID 7537796, PMID 8836420
U10CA032102 (3), P30CA016672 (2), 2017 (1), 2023 (1), 2025 (1), P30CA006973 (1), P30CA043703 (1), U01CA079778 (1), U01CA080098 (1), U10CA027469 (1), U10CA180821 (1), U10CA180868 (1)